4//SEC Filing
Palash Tzvi 4
Accession 0001209191-10-045333
CIK 0001006281other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 7:37 PM ET
Size
5.9 KB
Accession
0001209191-10-045333
Insider Transaction Report
Form 4
Palash Tzvi
Chief Operating Officer
Transactions
- Award
Stock Options (Right to Buy)
2010-08-29+160,000→ 160,000 totalExercise: $7.55Exp: 2020-08-29→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]The options vest over a four-year period. The first 25% of the options vest on the first anniversary of the grant date and the remaining 75% of the options vest in 12 equal tranches on a quarterly basis during the subsequent three-year period.
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001500830
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 7:37 PM ET
- Size
- 5.9 KB